Preliminary analysis of a phase II study of Heptazyme™, a nuclease resistant ribozyme targeting hepatitis C virus (HCV) RNA.

被引：0

作者：

Tong, M

Schiff, E

Jensen, DM

Jacobsen, I

Eversen, G

McHutchison, JG

Aitchison, R

Gordon, GS

Babcock, SA

Enright, JH

Maloney, L

Sandberg, JA

Blatt, L

机构：

[1] Huntington Mem Hosp, Pasadena, CA USA

[2] Univ Miami, Sch Med, Miami, FL 33152 USA

[3] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA

[4] New York Presbyterian Hosp, New York, NY USA

[5] Univ Colorado, Hlth Sci Ctr, Denver, CO 80202 USA

[6] Scripps Clin, La Jolla, CA USA

[7] Ribozyme Pharmaceut Inc, Boulder, CO USA

来源：

HEPATOLOGY | 2002年 / 36卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

788

引用

页码：360A / 360A

页数：1

共 50 条

[31] A CASE OF HEPATITIS-C VIRUS (HCV)-ASSOCIATED ARTHRITIS - QUANTITATIVE-ANALYSIS OF HCV RNA OF THE SYNOVIAL-FLUID AND THE SERUM
UENO, Y
KINOSHITA, R
TSUJINOUE, H
KATO, M
BRITISH JOURNAL OF RHEUMATOLOGY, 1995, 34 (07): : 691 - 692
[32] Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study)
Calvaruso, Vincenza
Bronte, Fabrizio
Ferraro, Donatella
Reina, Giada
Conte, Elisabetta
Rini, Francesca
Magro, Bianca
Petta, Salvatore
Di Marco, Vito
Craxi, Antonio
LIVER INTERNATIONAL, 2019, 39 (12) : 2240 - 2243
[33] IMPROVEMENT OF HEPATITIS-C VIRUS (HCV) RNA PCR THROUGH A MULTICENTER QUALITY-CONTROL STUDY
ZARSKI, JP
HEPATOLOGY, 1993, 18 (04) : A86 - A86
[34] NATURAL CLEARANCE OF HEPATITIS C VIRUS (HCV) RNA IN CHRONIC HCV CARRIERS: A LONG-TERM COHORT STUDY IN AN ENDEMIC AREA OF HCV INFECTION IN JAPAN
Watanabe, Hisayoshi
Saito, Takufumi
Nishise, Yuko
Sasaki, Yayoi
Sato, Chikako
Ishii, Rika
Haga, Hiroaki
Sanjo, Mai
Okumoto, Kazuo
Ito, Junitsu
Saito, Koji
Shinzawa, Horuhide
Kawata, Sumio
HEPATOLOGY, 2009, 50 (04) : 1053A - 1053A
[35] Evaluation of hepatitis C virus (HCV) core antigen assay from venepuncture compared to HCV RNA in plasma: a cohort study from Pakistan
Hamid, Saeed Sadiq
Abid, Adeel
Gulab, Muraduddin
Sallahuddin, Sultan
Awan, Safia
Cloherty, Gavin
JOURNAL OF HEPATOLOGY, 2021, 75 : S776 - S776
[36] Comparative study of hepatitis C virus RNA quantification by the Quantiplex™ HCV 2.0 RNA (Chiron diagnostics) and the Amplicor HCV Monitor™ 2.0 (Roche diagnostics systems) assays
Fritsch, S
Freitag, R
Schmitt, C
Labouret, N
Stoll-Keller, F
HEPATOLOGY, 1999, 30 (04) : 613A - 613A
[37] Optimal Frequency of Hepatitis C Virus (HCV) RNA Testing for Detection of Acute HCV Infection Among At-risk People With Human Immunodeficiency Virus: A Multicenter Study
Sun, Hsin-Yun
Liou, Bo-Huang
Chen, Tun-Chieh
Yang, Chia-Jui
Huang, Sung-Hsi
Lu, Po-Liang
Huang, Chung-Hao
Tsai, Mao-Song
Cheng, Shu-Hsing
Lee, Nan-Yao
Ko, Wen-Chien
Chen, Yen-Hsu
Liu, Wang-Da
Lin, Shang-Yi
Lin, Shih-Ping
Chen, Po-Lin
Syue, Ling-Shan
Huang, Yu-Shan
Chuang, Yu-Chung
Chen, Cheng-Bin
Chang, Ya-Ting
Lee, Yuan-Ti
Hsieh, Szu-Min
Su, Li-Hsin
Cheng, Chien-Yu
Hung, Chien-Ching
OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (06):
[38] A phase II pilot study for the treatment of HCV RNA positive blood donors with minimal or mild chronic hepatitis (CH).
Prati, D
Zanella, A
Zanuso, F
Vianello, L
De Mattei, C
Farma, E
Bosoni, P
Mozzi, F
Picone, A
Sirchia, G
Colombo, M
Donate, MF
De Fazio, C
Carriero, PL
Zahm, F
TRANSFUSION, 1998, 38 (10) : 93S - 93S
[39] A phase II pilot study for the treatment of HCV RNA positive blood donors with minimal or mild chronic hepatitis (CH).
Prati, D
Zanella, A
Zanuso, F
Vianello, L
De Mattei, C
Farma, E
Bosoni, P
Mozzi, F
Picone, A
Colombo, M
Donato, MF
De Fazio, C
Carriero, PL
Zahm, F
Sirchia, G
HEPATOLOGY, 1998, 28 (04) : 211A - 211A
[40] Analysis of Naturally Occurring Resistant Mutations to Hepatitis C Virus NS3 Protease Inhibitors: A Preliminary Study in South of Iran
Afrasiabi, Mozhgan
Hosseini, Seyed Younes
Yaghobi, Ramin
Fattahi, Mohammad-Reza
Ardebili, Maryam
Khodadad, Mahboobeh
JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (10)

← 1 2 3 4 5 →